FDA — authorised 25 September 2006
- Application: NDA021947
- Marketing authorisation holder: CEPHALON
- Local brand name: FENTORA
- Indication: TABLET — BUCCAL, SUBLINGUAL
- Status: approved
FDA authorised Fentanyl Buccal Tablet on 25 September 2006
Yes. FDA authorised it on 25 September 2006.
CEPHALON holds the US marketing authorisation.